Capricorn Fund Managers Ltd Makes New Investment in Taysha Gene Therapies, Inc. $TSHA

Capricorn Fund Managers Ltd purchased a new stake in Taysha Gene Therapies, Inc. (NASDAQ: TSHA) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 300,000 shares of the company's stock, valued at approximately $1,650,000. Capricorn Fund Managers Ltd